| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of Psychiatry (A.B.) and Neurology (B.C.D.), Massachusetts Alzheimer's Disease Research Center and Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston; Division of Cognitive and Behavioral Neurology (B.C.D.), Department of Neurology, Brigham & Women's Hospital, Boston, MA; and Department of Neurology and Alzheimer's Disease Research Center (J.C.M.), Washington University School of Medicine, St. Louis, MO.
* To whom correspondence should be addressed. E-mail: bradd{at}nmr.mgh.harvard.edu.
Objective: We previously used exploratory analyses across the entire cortex to determine that mild Alzheimer disease (AD) is reliably associated with a cortical signature of thinning in specific limbic and association regions. Here we investigated whether the cortical signature of AD-related thinning is present in individuals with questionable AD dementia (QAD) and whether a greater degree of regional cortical thinning predicts mild AD dementia.
Methods: Participants included 49 older adults with mild impairment consistent with mild cognitive impairment (Clinical Dementia Rating [CDR] = 0.5) at the time of structural MRI scanning. Cortical thickness was measured in nine regions of interest (ROIs) identified previously from a comparison of patients with mild AD and controls.
Results: Longitudinal clinical follow-up revealed that 20 participants converted to mild AD dementia (progressors) while 29 remained stable (nonprogressors) approximately 2.5 years after scanning. At baseline, QAD participants showed a milder degree of cortical thinning than typically seen in mild AD, and CDR Sum-of-Boxes correlated with thickness in temporal and parietal ROIs. Compared to nonprogressors, progressors showed temporal and parietal thinning. Using receiver operating characteristic curves, the thickness of an aggregate measure of these regions predicted progression to mild AD with 83% sensitivity and 65% specificity.
Conclusions: Thinning in specific cortical areas known to be affected by Alzheimer disease (AD) is detectable in individuals with questionable AD dementia (QAD) and predicts conversion to mild AD dementia. This method could be useful for identifying individuals at relatively high risk for imminent progression from QAD to mild AD dementia, which may be of value in clinical trials.
Related Article
This article has been cited by other articles:
|
|
 |
|
  In Search of the Cortical Signature of Early Alzheimer Disease Journal Watch Neurology, November 10, 2009; 2009(1110): 1 - 1. [Full Text]
|
|
|
|
 |
|
 B. S. Peterson and M. M. Weissman Reply to Pomara et al: Spatially distributed patterns of cortical thinning likely constitute distinct brain-based biomarkers for disease PNAS, July 21, 2009; 106(29): E83 - E83. [Full Text] [PDF]
|
|
|
|
|
|
N. Pomara and J. Sidtis Does cortical thinning in persons at increased risk for major depression also increase their risk for Alzheimer's disease? PNAS, July 21, 2009; 106(29): E82 - E82. [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Rottenberg Thin skin: The cortical signature of prodromal AD? Neurology, March 24, 2009; 72(12): 1038 - 1039. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
